Clinical Trials
20 trialsNCT04660929 2024-12-18
CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors
Carisma Therapeutics Inc
Phase 1 Unknown
NCT06427291 2024-05-23
Clinical Study of T3011 Intravesical Instillation for Treatment of NMIBC Patients
Fudan University
Phase 1 Unknown
NCT04134000 2024-05-21
BladderGATE
Fundacion Oncosur
Phase 1 Unknown
NCT05829057 2024-02-13
The IIT Study of Evaluation of P-IL-2 Single Agent and With Anti-PD-1
Zhejiang University
Phase 1 Unknown
NCT04149691 2024-02-07
Safety, Tolerability and Pharmacokinetics of Oral CPL304110, in Adult Subjects With Advanced Solid Malignancies
Celon Pharma SA
Phase 1 Unknown
NCT05259319 2023-10-17
IMMUNOs-SBRT
Centre Georges Francois Leclerc
Phase 1 Unknown
NCT06034015 2023-09-13
A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of APL-1501 Extended Release (ER) Capsules Compared to APL-1202 Immediate Release (IR) Tablets in Healthy Volunteers
Jiangsu Yahong Meditech Co., Ltd aka Asieris
Phase 1 Unknown
NCT03634982 2022-09-01
Dose Escalation of RMC-4630 Monotherapy in Relapsed/Refractory Solid Tumors
Revolution Medicines, Inc.
Phase 1 Unknown
NCT03934827 2022-08-11
MICROBIOME
Imperial College London
Phase 1 Unknown
NCT04819399 2022-04-05
Investigation of Safety and Tolerability of Catumaxomab in Patients With NMIBC
Lindis Biotech GmbH
Phase 1 Unknown
NCT05235607 2022-02-11
Personalized Immune Cell Therapy Targeting Neoantigen of Malignant Solid Tumors
Sichuan University
Phase 1 Unknown
NCT05124106 2021-12-13
In Vivo Proof-of-principle Study of Raman Spectroscopy in Trial Participants With Bladder Tumours
University Hospital Bispebjerg and Frederiksberg
Phase 1 Unknown
NCT03583125 2019-09-11
Study of EOC317 in Chinese Patients With Advanced Solid Tumors
Taizhou EOC Pharma Co., Ltd.
Phase 1 Unknown
NCT03464032 2018-03-13
A Study of BCD-135 in Patients With Advanced Solid Tumors
Biocad
Phase 1 Unknown
NCT02457650 2016-08-03
T Cell Receptor-transduced T Cells Targeting NY-ESO-1 for Treatment of Patients With NY-ESO-1- Expressing Malignancies
Shenzhen Second People's Hospital
Phase 1 Unknown
NCT01124682 2013-08-26
3-Dimensional Conformal Radiation Therapy in Treating Patients With Bladder Cancer Who Have Undergone Transurethral Resection of the Bladder
National Cancer Institute (NCI)
Phase 1 Unknown
NCT00959868 2012-02-13
A Study for Treatment of Superficial Bladder Cancer Using OGX-427
Vancouver Coastal Health
Phase 1 Unknown
NCT00710697 2009-09-24
Cardiac Safety Assessment Study of Picoplatin in Solid Tumors
Poniard Pharmaceuticals
Phase 1 Unknown
NCT00109655 2008-10-03
Dose-Escalation Study of CG0070 for Bladder Cancer After BCG (Bacillus Calmette-Guerin) Failure
Cell Genesys
Phase 1 Unknown
NCT00090727 2006-11-02
Chemotherapy for Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma
Novacea
Phase 1 Unknown